Functional Brands Inc. Announces P2i(TM) by Kirkman(R) as the World's First Prenatal Supplement to Fully Align with FIGO's Transparency Standards - and the First to Comply with California's New SB 646 QR-Code Disclosure Law
Rhea-AI Summary
Functional Brands (NASDAQ: MEHA) announced that P2i by Kirkman Prenatal Multivitamin & Multimineral is the first prenatal supplement to align testing and transparency with FIGO standards and the first prenatal product to comply with California's SB 646 QR-code disclosure law. The product already includes an on-package QR code linking to batch-specific Certificates of Analysis showing results for 120 toxicants and 24 heavy metals, plus microbiological and allergen panels. The company provides searchable public lab reports, downloadable lot summaries, and testing-method documentation for clinicians and consumers.
Positive
- None.
Negative
- None.
News Market Reaction – MEHA
On the day this news was published, MEHA gained 3.86%, reflecting a moderate positive market reaction. Argus tracked a peak move of +6.3% during that session. Argus tracked a trough of -6.7% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $102K to the company's valuation, bringing the market cap to $3M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 08 | Investor conference | Neutral | +5.9% | Announcement of participation in Sidoti virtual investor conference and webcast. |
| Dec 02 | Product transparency | Positive | +3.9% | P2i prenatal supplement aligned with FIGO standards and California SB 646. |
| Nov 24 | Shareholder letter | Positive | +10.4% | Shareholder letter detailing direct listing, revenue, margin gains, and growth plan. |
| Nov 10 | Commercial partnership | Positive | +3.3% | Partnership with Market Performance Group to expand Kirkman brand distribution. |
Recent corporate and product news has generally been followed by positive price reactions in the first 24 hours.
This announcement continues a news flow focused on the Kirkman brand and growth positioning. A recent shareholder letter highlighted consistent net revenue of $6.5 million and a 1,300 basis-point gross margin improvement, along with a direct listing on November 5, 2025. A commercial partnership with Market Performance Group and participation in an investor conference also preceded positive single‑digit price moves. The current FIGO- and SB 646-aligned prenatal testing disclosure extends the transparency and quality narrative already emphasized in prior communications.
Market Pulse Summary
This announcement highlights that P2i by Kirkman underwent testing for 120 toxicants and 24 heavy metals, with results accessible via on-package QR codes linking to Certificates of Analysis. It also notes early alignment with California’s SB 646 ahead of its expected January 2027 effective date. In the context of prior disclosures on revenue stability and margin gains, investors may watch how this transparency positioning supports broader commercialization of the Kirkman brand.
Key Terms
toxic heavy metals medical
QR code technical
Certificate of Analysis technical
microbiological medical
allergen panels medical
AI-generated analysis. Not financial advice.
Lake Oswego, Oregon--(Newsfile Corp. - December 2, 2025) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that P2i™ by Kirkman® Prenatal Multivitamin & Multimineral is the first prenatal supplement in the world to align its testing and transparency practices with the International Federation of Gynecology and Obstetrics (FIGO) position statement on toxic chemicals and environmental contaminants in prenatal vitamins — and the first prenatal product to already comply with California Senate Bill 646 (SB 646).
SB 646 is the first law in the United States to require testing and public disclosure of toxic heavy metals in prenatal supplements and to mandate a QR code on packaging linking directly to detailed test results.
"P2i by Kirkman was designed to meet an urgent need: expectant parents deserve prenatal nutrition that's not only scientifically formulated for development but also transparently tested and openly documented," said Eric Gripentrog, CEO of Functional Brands Inc. "From the start, we built P2i to reflect FIGO's call for vigilance around contaminants and we implemented QR-code transparency on our outer packaging and web page well ahead of California's new requirements, so parents and clinicians can instantly access test results."
Why This Matters
FIGO's global position statement calls for stronger oversight of toxic chemicals and contaminants in prenatal vitamins and urges rigorous testing and transparency to help clinicians and pregnant people make informed choices. P2i's testing protocols and disclosure format were created to meet those exact standards.
California's SB 646—the first U.S. law to mandate comprehensive heavy-metal testing and public disclosure for prenatal supplements—aims to improve maternal and fetal safety by ensuring consumers have direct access to verified testing data. While the law is expected to take effect in January 2027, P2i™ by Kirkman® is already providing full compliance with an on-package QR code that links to its Certificate of Analysis to see exactly what is being tested and the actual results for each production batch.
What Kirkman® Is Disclosing
- Comprehensive Testing: P2i is analyzed for 120 toxicants and 24 heavy metals, along with extensive microbiological and allergen panels.
- QR Code on Every Package: Each product box includes a readable QR code links to the latest test results online and product identifiers (UPC, lot, batch, and size).
- Public Lab Reports: The QR link provides searchable, publicly accessible test reports showing measured levels for each tested element — mirroring the disclosure standards required by SB 646.
Clinician & Consumer Resources
Kirkman® offers downloadable test summaries for each respective P2i by Kirkman production lots, detailed explanations of testing methods, and analytical lab methods used, and simple guidance on pass/fail results. Clinicians and consumers are encouraged to review full lab documentation via the QR code or product web pages.
About Functional Brands Inc.
Functional Brands Inc. is a health and wellness company focused on acquiring and growing science-based consumer brands. With a portfolio that includes trusted names like Kirkman®, P2i by Kirkman®, Hemptown Naturals, Healthy Assist by Kirkman; Functional Brands is committed to providing high-quality, effective solutions that support healthier lives.
For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com.
Investor Relations Contact:
FunctionalBrands@icrinc.com
Cautionary Note Regarding Forward-Looking Statements
This news release and statements of Functional Brands's management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control.
Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands's Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276520
FAQ
What did Functional Brands announce about P2i by Kirkman (MEHA) on December 2, 2025?
How does the P2i by Kirkman QR code comply with California SB 646 for MEHA products?
What contaminants and tests are disclosed for P2i by Kirkman (MEHA)?
When will California's SB 646 take effect and is P2i already compliant for MEHA?
Where can clinicians and consumers for MEHA review P2i by Kirkman test results?
